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Background: Diva (death inducer binding to vBcl-2 and Apaf-1)/BclB is a Bcl-2 family member, which is known for
its function in apoptosis. Diva/BclB has been shown to interact with NDPKB/Nm23H2, which is involved in cellular
differentiation. Thus far, there has been no direct evidence of Diva/BclB having a role in differentiation. In the
present study, we investigated the expression of Diva/BclB and NDPKB/Nm23H2 during differentiation in PC-12
cell line.
Results: Our results show that after differentiation, Diva/BclB expression was decreased and reciprocally, NDPKB/
Nm23H2 expression was increased and it translocated into the nucleus. Overexpression of NDPKB/Nm23H2
promoted PC-12 neuronal differentiation by increasing neurite outgrowth and arresting cell cycle progression.
There was a concurrent downregulation of Diva/Boo when NDPKB/Nm23H2 was overexpressed, which mirrors the
effect of NGF on PC-12 cell differentiation. Overexpression of Diva/BclB did not change the expression level of
NDPKB/Nm23H2, but inhibited its nuclear localization. Cells that overexpressed Diva/BclB presented a decreased
percentage of differentiated cells and average neurite length was shortened. This was due to an increase in the
formation of Diva/BclB and NDPKB/Nm23H2 complexes as well as Diva/BclB and β-tubulin complexes.
Concomitantly, there was a decrease in formation of NDPKB/Nm23H2 and β-tubulin complexes. Overexpression
of Diva/BclB also resulted in a higher percentage of S-phase cells.
Conclusion: Our results showed a novel role for Diva/BclB in neuronal differentiation. Its downregulation during
neuronal differentiation may be necessary to allow NDPKB/Nm23H2 and β-tubulin interaction that promotes
NDPKB/Nm23H2 mediated differentiation.
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The PC-12 cell line has been used extensively as a model
of neuronal differentiation, as the cells halt proliferation,
have outgrowth of neurites and acquire properties of
sympathetic neurons after exposure to nerve growth fac-
tor (NGF) [1]. The differentiation response starts with
the stimulation of receptor tyrosine kinase (TrkA) which
activates the intracellular signal transduction cascades,
including those mediated by Raf-MAPK kinase-ERK and
other pathways regulated by Rho family of small
GTPases [2]. During the last few years, there have also* Correspondence: anthebp@nus.edu.sg
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reproduction in any medium, provided the orbeen reports of negative regulators of neuronal differen-
tiation in PC-12 cells, such as Sprouty (Spry) family of
proteins and Idh3α [3,4].
Diva/BclB is a member of the Bcl-2 family of proteins.
A human ortholog has also been identified, and desig-
nated as BclB or Bcl2l10. It is also known as Boo (Bcl-2
homologue of ovary). Diva/BclB contains BH1, BH2,
BH3, and BH4 regions and a carboxyl-terminal hydro-
phobic domain. It is distributed in the brain, liver, and
heart of E15 embryonic mice. Interestingly, in adult mice
the expression of Diva/BclB decreases dramatically and
becomes restricted to the granulosa cells of the ovary
and the seminiferous tubules of the testis [5]. Diva/BclB
labeling in seminiferous tubules is consistent with a
stage-specific expression during spermatogenesis. Thus. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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effect on apoptosis. Diva/BclB has been reported to form
a ternary complex with apoptosis-activating factor-1
(Apaf-1) and caspase-9, to induce BH-3 independent cell
death [5]. However, Boo was reported to inhibit apop-
tosis through homodimerization or heterodimerization
with some pro-apoptotic (Bak and Bid) and anti-
apoptotic (Bcl-2 and Bcl-xl) Bcl-2 family members [6].
More recently, Diva/BclB was shown to mediate cell
death through interaction with a nucleoside diphosphate
kinase (NDPK) isoform, NM23-H2/NDPK B [7].
Nm23/NDPK are house keeping enzymes needed for
transfer of the terminal phosphate of a nucleoside tri-
phosphate to a nucleoside diphosphate. Out of the ten
known human Nm23 family genes, NDPKA/Nm23H1
and NDPKB/Nm23H2 are the most abundant and ubi-
quitous isoforms, and are located both in the nuclei and
cytoplasm [8]. Apart from its kinase activity, Nm23/
NDPK has been suggested to be involved in a variety
of cellular functions including differentiation, prolifera-
tion, gene regulation and apoptosis [9-11]. Overexpres-
sion of Nm23-M1 protein induced neurite outgrowth and
increased the expression of neurofilament and micro-
tubule proteins, whereas downregulation of Nm23/NDPK
enhanced cell proliferation and inhibited neuronal differ-
entiation [12].
Thus far, the physiological role of Diva/BclB has re-
mained elusive due to a paucity of information. Even its
function in apoptosis is highly controversial with many
opposing reports. Recently, there has been evidence of
Diva/BclB having a direct role in development. Knockdown
of the zebrafish ortholog (NRZ) resulted in disorganized
somites, increased levels of Snail-1, and disorganisation
of the microtubule network and F-actin depolymerisation
in the yolk sac [13,14]. Diva/BclB has a decreased expres-
sion pattern during development, and is known to interact
with NDPKB/Nm23H2 which is involved in cellular differ-
entiation. These findings prompted us to investigate if
Diva/BclB also has a role in cellular differentiation. Using
overexpression studies, we demonstrated that Diva/BclB
negatively regulates PC-12 neuronal differentiation, by
affecting neurite outgrowth and cell proliferation. Further-
more, we report that Diva/BclB mediates these processes
through its interaction and regulation of subcellular
localization of NDPK B/Nm23H2.
Results
Up-regulation of NDPKB and down-regulation of Diva
during neuronal differentiation
To address whether NDPKB/Nm23H2 and Diva/BclB
may play physiological roles in neuronal differentiation,
we examined the expression of these proteins during
PC-12 neuronal differentiation. PC-12 cells showed a
steady and significant increase in NDPKB/Nm23H2 andβ-tubulin mRNA levels, with a concurrent decrease in
Diva/BclB mRNA levels during the course of NGF-
induced differentiation (Figure 1A). Detection of protein
expressions using immunocytochemistry also showed the
up-regulation of NDPKB/Nm23H2 and down-regulation
of Diva/BclB (Figure 1B).
In the cells not treated with NGF, the distribution of
Diva/BclB was detected to be in the cytoplasm, and
NDPKB/Nm23H2 was mostly in the cytoplasm with some
cells staining positive for the nucleus as well. By 3 days
after NGF-induced differentiation, the cells expressed a
lesser amount of Diva/BclB and this low expression was
maintained at 5 days after differentiation. In contrast,
differentiated cells stained more intensely for NDPKB/
Nm23H2 after 3 days of differentiation and remain ele-
vated even at 5 days, and a greater percentage of cells
showed staining for the nucleus as compared to the con-
trol (Figure 1B). Statistical analysis showed the percentage
of cells with NDPKB/Nm23H2 B in the nucleus was sig-
nificantly elevated after the cells differentiate (Figure 1C).
NDPKB/Nm23H2 protein promotes outgrowth of neurites
In order to investigate if the increased expression
NDPKB/Nm23H2 were directly involved in the process
of differentiation, we overexpressed NDPKB/Nm23H2 in
the PC-12 cell line. For this purpose, PC-12 cells were
transfected with 2μg of control and NDPKB/Nm23H2
plasmids. Quantification of protein levels (Figure 2A)
showed that overexpression of NDPKB/Nm23H2 resulted
in a significant increase in NDPKB/Nm23H2 levels, upre-
gulation in β-tubulin levels, and downregulation in Diva/
BclB expression. This is similar to the expression profile of
these proteins during NGF-induced differentiation.
The ectopic NDPKB/Nm23H2 protein was expressed
in both nucleus and cytoplasm of the transfected cells
(Figure 2B). Even without NGF treatment, the NDPKB/
Nm23H2 overexpressing cells also had little branches
appearing, suggesting that NDPKB/Nm23H2 might
help to initiate neuronal differentiation. When exposed
to NGF, the cells overexpressing NDPKB/Nm23H2 also
had a more branched morphology, with greater out-
growth of neurites (Figure 2B). Ectopic NDPKB/
Nm23H2 was expressed in both nucleus and cytoplasm
of the transfected cells, therefore leading to significant
increases in the percentages of undifferentiated and dif-
ferentiated cells with NDPKB/Nm23H2 in their nucleus
(Figure 2C). Cells that overexpressed NDPKB/Nm23H2
had 82.4±2.81% differentiated cells, which was signi-
ficantly more than the 64.86±3.39% in the control
(Figure 2D). They also had longer neurites, measuring
35.42.6 ± 1.54 μm as compared to 28.74 ± 1.55 μm in
control cells (Figure 2E). Therefore, this shows that
upregulation of NDPKB/Nm23H2 during differentiation
facilitates neurite outgrowth.
Figure 1 Reciprocal expression of Diva/BclB and NDPKB/Nm23H2 proteins in differentiated PC-12 cells. (A) Real time-PCR showed
decreased expression of Diva/BclB mRNA and upregulation of NDPKB/Nm23H2 and β-tubulin expressions. The data was normalized using GAPDH
expression. (B) Western blotting show protein levels follow the same trend after differentiation. (C) Immunocytochemistry staining with Diva/
BclB (green) and NDPKB/Nm23H2 (red) antibodies show colocalization of both proteins in the cytoplasm. (D) Nuclear staining of NDPK B was
observed in differentiated cells, and the percentage of cells with NDPKB/Nm23H2 in the nucleus was quantified after counting an average of
300 cells. Bar=40μm; *p<0.05, ***p<0.001.
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Figure 2 Overexpression of NDPKB/Nm23H2 increases cell differentiation and neurite length. The PC-12 cells were harvested or
fixed 24hrs post-transfection. (A) Immunoblotting showed that overexpression of NDPKB/Nm23H2 suppresses expression of Diva/BclB. (B)
Immunocytochemistry staining with Diva/BclB (green) and NDPKB/Nm23H2 (red) antibodies show colocalization of both proteins in the
cytoplasm. (C) The percentages of cells with NDPKB/Nm23H2 in the nucleus were greatly elevated after the protein was overexpressed.
Both the percentage of differentiated cells (D) and average neurite length (E) of the differentiated cells were increased in the NDPKB/
Nm23H2 overexpressing cells. An average of 150 cells per group was counted for graphical analyses, and the experiments were
performed in triplicate (Bar=40μm, *p<0.05, **p<0.01, ***p<0.001).
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translocation of NDPKB/Nm23H2 into the nucleus
during differentiation
Since NGF-induced differentiation of PC-12 cells as well
as NDPKB/Nm23H2 overexpression resulted in downre-
gulation of Diva/BclB expression, we next investigated if
Diva/BclB might be a negative regulator of neuronal
differentiation. For this purpose, PC-12 cells were trans-
fected with control or Diva/BclB plasmid. Overexpres-
sion of Diva did not affect the protein expression level
of β-tubulin and NDPKB/Nm23H2 (Figure 3A). In the
undifferentiated cells, overexpression of Diva/BclB resulted
in a slight but non-significant increase in percentage
of cells with NDPKB/Nm23H2 in the nucleus, so the
majority of the protein was still expressed in the cy-
toplasm (Figure 3B). However, in the differentiated
cells, ectopic expression of Diva/BclB affected NDPKB/
Nm23H2 localization and cellular morphology. Cells
with strong expression of Diva/BclB had shorter neurites
with strong co-localization of Diva/BclB and NDPKB/
Nm23H2 at the neurite terminal (white arrow), whereas
cells with downregulated Diva/BclB expression had long
neurites. Diva/BclB overexpressing cells had 53.76±3.75%
differentiated cells, which was significantly lesser than
the 64.86±3.39% in the control (p<0.05) (Figure 3D).
Diva/BclB overexpressing cells also had shorter neurites,
measuring 25.6 ± 0.66μm as compared to 28.74 ± 1.55
μm in control cells (p<0.05) (Figure 3E).
While the control cells that were differentiated had
translocation of NDPKB/Nm23H2 to the nucleus, cells
that were overexpressing Diva/BclB had most of their nu-
cleus unstained with the NDPKB/Nm23H2 antibody des-
pite differentiation (Figure 3B). Analysis showed that the
percentage of differentiated cells with NDPKB/Nm23H2
in their nucleus was lesser in Diva-overexpressing cells
(Figure 3C), indicating that Diva might be sequestering
NDPKB/Nm23H2 in the cytoplasm.
Diva/BclB inhibits neurite outgrowth by preventing the
association of NDPKB/Nm23H2 and β-tubulin
As it is known that β-tubulin is a component of micro-
tubules, and that neuritogenesis requires changes to
the cytoskeletal network, we studied the interactions of
Diva/BclB, NDPKB/Nm23H2 and β-tubulin to furtherunderstand the mechanism through which Diva/BclB
inhibited neurite outgrowth. Using Duolink kit, which is
a proximity ligation assay kit, we examined the subcellu-
lar locations and amounts of Diva/BclB and NDPKB/
Nm23H2, NDPKB/Nm23H2 and β-tubulin as well as
Diva/BclB and β-tubulin complexes.
Overexpression of Diva/BclB led to increased amounts
of Diva/BclB and NDPKB/Nm23H2, as well as Diva/
BclB and β-tubulin complexes in undifferentiated cells.
This was maintained at a relatively high number even
after differentiation (Figure 4A & B). In contrast, over-
expression of Diva/BclB resulted in fewer NDPKB/
Nm23H2 and β-tubulin complexes in both undifferen-
tiated and differentiated cells (Figure 4C). Hence, the
interaction between Diva/BclB and NDPKB/Nm23H2
would retain NDPKB/Nm23H2 in the cytosol and pre-
vent interaction of NDPKB/Nm23H2 and β-tubulin,
which then results in decreased neurite outgrowth.
Diva/BclB increases and NDPKB/Nm23H2 decreases
cell proliferation
Next, we examined the effects of Diva/BclB and
NDPKB/Nm23H2 on cell proliferation as cell cycle exit
is one of the hallmarks of neuronal differentiation. To
this end, we compared the proliferation rates of the
undifferentiated and differentiated transfected cells, by
staining them with Brd-U antibodies 24 hours after dif-
ferentiation (Figure 5A). NDPKB/Nm23H2 overexpres-
sing cells in the control group had a significantly lesser
number of cells that were in S phase (Figure 5B). In fact,
the number of dividing cells in the undifferentiated
NDPKB/Nm23H2 was similar to the differentiated con-
trol group, suggesting that increased NDPKB/Nm23H2
expression is responsible for the decreased proliferation
during differentiation in normal cells. Overexpression of
NDPKB/Nm23H2 was also able to further decrease the
number of cycling cells in the differentiated group
(Figure 5B). In contrast, Diva/BclB overexpressing cells
had a higher percentage of cells nuclei with BrdU stain-
ing (Figure 5A & B). Hence, ectopic Diva/BclB expres-
sion results in an elevated proliferation rate.
Using MTS assay, growth curves for control, Diva/BclB
and NDPKB/Nm23H2 were plotted over a 4 day period
(Figure 5C). For the undifferentiated cells, NDPKB/
Figure 3 (See legend on next page.)
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Figure 3 Overexpression of Diva/BclB decreases cell differentiation and neurite length. After transfection with either the empty vector
(control) or Diva/BclB overexpressing plasmid(Diva/BclB), immunoblotting (A) both showed an increase in Diva/BclB expression without
any change to NDPKB/Nm23H2 expression. (B) Overexpression of Diva (green) resulted in stronger immunostaining in the cytoplasm.
There was no change in NDPKB/Nm23H2 (red) expression. In the Diva/BclB cells, Diva/BclB expression remained strong even after 24 hrs
of differentiation. There was strong colocalization of both proteins in the cytoplasm and at the neurite. (C) Overexpression of Diva/BclB
prevents translocation of NDPKB/Nm23H2 into the nucleus after differentiation. It also decreases the percentage of differentiated cells (D)
and their average neurite length (E). An average of 150 cells per group was counted for graphical analyses, and the experiments were
performed in triplicate (Bar =40μm, *p<0.05, **p<0.01).
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control, whereas Diva/BclB cells had a peak in cell num-
bers at 2 days after plating. However, by 4 days all the
transfected cells had similar cell numbers, plausibly due to
space constraints in the well. The growth curves for all
the differentiated transfected cells were attenuated, indi-
cating a slower proliferation rate as compared to the un-
differentiated cells. There was a significant increase in cell
number of Diva/BclB cells as compared to control cells
only 4 days after induction of differentiation. The growth
curve for NDPKB/Nm23H2 overexpressing cells was
slightly slower than the control cells when under differen-
tiating conditions, but statistical analysis showed no sig-
nificant difference.
In order to study the effects of both proteins on
serum-induced cell cycle re-entry, the transfected cells
were serum starved for 24 hours to arrest and
synchronize them, before serum was added again to
allow cell cycle re-entry. At stipulated time points after
re-addition of serum, the cells were stained with propi-
dium iodide and subjected to flow cytometry analysis.
Both Diva/BclB and NDPKB/Nm23H2 overexpressing
cells had significantly lower percentages of apoptotic
cells (Figure 5D). There was a delay in progression
from G1 to S-phase for the NDPKB/Nm23H2 cells
(Figure 5E) and there was a significant S-phase popula-
tion only at 24hrs (Figure 5F). The G2/M population for
NDPKB/Nm23H2 cells was consistently smaller than the
control cells (Figure 5G). In contrast, the Diva/BclB cells
had a considerably larger S-phase population than the
control at 6 and 12 hrs (Figure 5F). Interestingly, at 12
hours, there was a greater proportion of Diva-
overexpressing cells at S-phase, and a lower percentage
in the G2/M phase, as compared to the control cells
(Figure 5G). Hence, it might signify that Diva has a role
in S-phase.
Discussion
Thus far, reports on Diva/BclB have only covered its role
in apoptosis and oocyte maturation [5,15,16]. The results
in this study propose a novel function for Diva/BclB, by
demonstrating that the protein is involved in the nega-
tive regulation of neuronal differentiation, and that it
achieves this by inhibiting NDPKB/Nm23H2 function.In this study, we showed that with NGF-induced
differentiation, Diva/BclB expression decreases and
NDPKB expression increases. The regulation of these
2 proteins is likely through the sustained ERK signal-
ling by NGF, which results in phosphorylation as well
as binding of CREB and AP-1 family members so as to
facilitate gene transcription [17,18].
Overexpression of NDPKB/Nm23H2 encouraged
PC12 neuronal differentiation by promoting neurite out-
growth and retarding cell proliferation. Interestingly,
there was Diva/BclB downregulation in the NDPKB/
Nm23H2 overexpressing cells, which is a salient point
since decreased expression of Diva/BclB was also
observed during NGF-induced differentiation. Thus, this
supported that Diva/BclB was a negative modulator of
neuronal differentiation that had to be downregulated
and suggested that the induced downregulation of Diva/
BclB by NDPKB/Nm23H2 could be a positive feedback
mechanism for NGF-induced neuronal differentiation.
Overexpression of Diva suppressed NDPKB/Nm23H2
function by retaining NDPKB/Nm23H2 in the cyto-
plasm, and attenuated the number of NDPKB/Nm23H2
and β-tubulin complexes. In turn, there was an increase
in S-phase cells and shorter neurites were observed after
NGF-induced neuronal differentiation.
The regulatory molecules that control the rate of neur-
ite growth and the signals that determine when and
where the axons and dendrites have to grow are still
largely unknown. Overexpression of negative regulators
of neuronal differentiation have been shown to block
neurite outgrowth and branching by inhibiting the Erk/
MAPK and Rac1 but not Akt signaling pathway in re-
sponse to NGF [3,19]. In our study, Diva/BclB inhibited
neurite outgrowth as more Diva/BclB and NDPKB/
Nm23H2 as well as Diva/BclB and β-tubulin complexes
were formed and the amount of NDPKB/Nm23H2 and
β-tubulin complexes decreased significantly. Previous
reports have reported the co-immunoprecipitation of
NDPK/Nm23 with β-tubulin, and the number of com-
plexes increases during the cellular differentiation
process [12,20]. Tubulin phosphorylation by NDPKB/
Nm23H2 would allow the microtubules to attach
more efficiently to the MAPs and increase microtubule
stability, thereby facilitating neurite outgrowth [21-24].
Figure 4 Diva/BclB prevents NDPKB/Nm23H2 and β-tubulin complex formation. After transfection, the cells were grown for a day under
normal growth medium or differentiating medium for 24 hrs. The interaction between the proteins were analysed using the Duolink assay.
Regardless of the differentiation status, there were more Diva/BclB and β-tubulin (A) and Diva/BclB and NDPKB/Nm23H2 (B) complexes, and
fewer NDPKB/Nm23H2 and β tubulin (C) complexes formed in Diva-overexpressing cells. (Bar= 20; *p<0.05, **p<0.01).
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role of Diva/BclB in undifferentiated cells might be to
inhibit the association between NDPKB/Nm23H2 and β-
tubulin. Expression of Diva/BclB is downregulated dur-
ing differentiation to allow more NDPKB/Nm23H2 and
β-tubulin complexes to form, thereby encouraging neuriteoutgrowth. This is interesting since Diva/BclB has been
shown to interact with Hungtington-interacting protein
1-related (H1P1R) protein and microtubule binding pro-
tein, translationally controlled tumor-associated protein
(TCTP) and thereby postulated to regulate the cytoskel-
eton [14,25]. Our study has plugged the gap to show
Figure 5 (See legend on next page.)
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Figure 5 Effect of Diva/BclB and NDPKB/Nm23H2 on the cell cycle and cellular proliferation of cells. (A) The number of cells in S phase
are visualised by BrdU staining (green) in the nucleus. Diva/BclB had the highest proportion of stained nuclei, followed by control and NDPKB/
Nm23H2 had the lowest proportion. (B) An average of 500 cells per group was counted, and quantitative analysis of the data showed that
overexpression of NDPKB/Nm23H2 decreased the percentage of S-phase cells, while Diva/BclB increased cellular proliferation. (C) Growth curves
of the control and transfected cells were plotted using MTS assay. Diva/BclB cells had a less inhibited growth curve, while NDPKB/Nm23H2 cells
had a slower growth curve, when compared to control cells. (D-G) Flow cytometry data was collected after serum starvation for 24 hours (0hr),
and at indicated times after serum addition. Graphical analysis using Summit software showed that overexpression of Diva/BclB resulted in a
decrease in apoptotic cells and faster cell cycle progression. In contrast, overexpression of NDPKB/Nm23H2 resulted in slower cell cycle
progression. (Bar=20μm, *p<0.05, **p<0.01).
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quential effect on neurite outgrowth.
In differentiated cells, the overexpression of Diva/BclB
in PC-12 cells resulted in intense immunostaining in the
cytoplasm, indicating the colocalisation of the 2 proteins,
and significantly decreased the number of cells with
NDPKB/Nm23H2 in their nucleus. This suggests that
overexpression of Diva/BclB was able to sequester
NDPKB/Nm23H2 in the cytoplasm and prevent its
translocation into the cytoplasm after receiving the sig-
nal for differentiation. This is interesting because over-
expression of NDPKB/Nm23H2 results in nuclear
expression and decreased cellular proliferation. In con-
trast, the effect of overexpressing Diva/BclB is a higher
proliferation rate and decreased nuclear expression of
NDPKB/Nm23H2. Hence, this suggests that Diva/BclB
is able to regulate proliferation by controlling the nu-
clear translocation of NDPKB/Nm23H2. NDPKs have
been reported to translocate to the nucleus, although
there is controversy whether NDPKA/Nm23H1 and
NDPKB/Nm23H2 visit the nucleus together or separ-
ately [22,26]. Also, reasons for NDPKB/Nm23H2 move-
ment into the nucleus are also unclear, though the
translocation has been observed to occur at certain cell
phase cycles, thereby suggesting NDPK/Nm23 are
required in the nucleus for gene regulation or to supply
dNTPs for replication [27]. NDPKB/Nm23H2 has been
identified as human transcription factor PuF, a
sequence-specific DNA-binding protein with affinity for
a nuclease-hypersensitive element (NHE) of the c-MYC
gene promoter [28,29]. NDPKB/Nm23H2 has also been
demonstrated to be capable of DNA binding, DNA
cleavage, as well as transcriptional activity that is inde-
pendent of phosphoryl transfer and NDPK activity [30].
Thus, we report a novel observation of the translocation
of NDPKB/Nm23H2 into the nucleus after differenti-
ation, which causes inhibition of proliferation and
retarded cell cycle progression, although the exact
mechanisms are yet to be further elucidated.
Conclusion
In conclusion, our results present a model in which
downregulation of Diva/BclB during differentiation is
necessary to allow increased formation of NDPKB/Nm23H2 and β-tubulin complexes for neurite out-
growth, and for NDPKB/Nm23H2 to enter the nucleus
to inhibit proliferation. Hence this clarifies the develop-
mental observation for the increased NDPKB/Nm23H2
expression seen during the onset of organogenesis in
the brain [31], as well as explains the attenuated Diva/
BclB expression in the adult brain [5]. Development
of the nervous system is a complex process, and the
correct expression of Diva and NDPKB/Nm23H2 pro-
teins are important in ensuring regulation of diverse cel-
lular processes including proliferation, differentiation
and synaptogenesis.Methods
Cell culture
The PC12 cell line is established from rat adrenal me-
dullary pheochromocytoma has been used as a model
for neuronal differentiation. PC12 cells were routinely
maintained at 37°C and 5% CO2 in DMEM (Sigma
Aldrich, USA) supplemented with 10% heat-inactivated
fetal bovine serum (FBS) (Hyclone, Germany). To differ-
entiate the cells, 50ng/ml of NGF (Invitrogen, USA) was
added to DMEM with 1% FBS (differentiating medium).
The differentiating medium was then either added to
1x106 cells in a flask (for real-time PCR and immuno-
precipitation studies), or 5x105 cells in a well (for im-
munocytochemistry studies). The media was replaced
with fresh differentiating medium every other day.Real-time polymerase chain reaction (RT-PCR)
After differentiation, total RNA was isolated from the
cells in each well of a 6-well plate using the RNeasy Mini
kit according to the manufacturer’s protocol (Qiagen).
The qRT-PCR was performed using a LightCycler
instrument (Roche, Germany) and QuantiTect SYBR
Green (Qiagen) according to manufacturer’s instruc-











The cells were seeded onto sterilized cover slips placed
in a 6-well plate. After differentiation, the cells were
fixed with 4% paraformaldehyde. Next, the cells were
blocked with 5 % horse serum for 1 hour at room
temperature and incubated with Diva (sc8740; Santa
Cruz), Bcl-B (sc101875; Santa Cruz, USA) and NDPK B
(L-14) (sc14789; Santa Cruz, USA), and β-tubulin
(sc9104; Santa Cruz, USA) antibodies (All diluted at
1:200) overnight at 4°C. The cells were washed before
incubation with secondary antibodies, Alexa Fluor® 488
or Alexa Fluor® 555 (1:200, Invitrogen, USA), for 1 hour
at room temperature. The cells were then washed,
before they were mounted onto glass slides with Vecta-
shield Mounting Medium with DAPI (Vector Labs,
USA). All images were captured using a confocal micro-
scope (Fluoview1000, Olympus, Japan).
Transfection of PC12 cells
The plasmids from the company Blue Heron Biotechnol-
ogy (USA) were used. The full length Diva and NDPK B
were cloned into pcDNA6A (Invitrogen, USA) with a
6xHis tag. 1x106 cells were seeded into a six well plate and
incubated at 37°C and 5% CO2 for 24 hours. 4μl
of Lipofectamine 2000; 2μg of pcDNA6A, pcDNA6A-Diva
and pcDNA6A-NDPK B were diluted in 250μl of OPTI-
MEM for 5 minutes respectively. The diluted Lipofecta-
mine 2000 reagent was then added to the diluted plasmids,
and the mixture was incubated at room temperature for
25 minutes. The cells were then incubated with the plasmids
for 5 hours at 37°C and 5% CO2. Thereafter, they were
rinsed with 1xPBS once, before fresh media was added.
Western blot
Equal amounts of protein were separated electrophoret-
ically using SDS-PAGE and then the gel was transferred
to 0.45 μm polyvinylidene fluoride (PVDF: Millipore,
USA). The membranes were soaked in blocking buffer
(5% skimmed milk) for 1 hour at room temperature and
then incubated overnight at 4°C with primary antibodies.
This was followed by washing with TBS-Tween and in-
cubation with secondary antibodies. For IP studies,
Clean-blot reagent (Thermoscientific, USA) was used
as it allows clear Western blot detection without IgG
bands. This was followed by visualization by the enhanced
chemiluminescence (ECL) detection system according to
the recommended procedure (Pierce, USA).
Duolink
The Duolink Kit I (Olink Bioscience, Sweden) was
used to study the direct interaction of the proteins. Inbrief, the wild type, pcDNA6A, pcDNA6A-Diva and
pcDNA6A-NDPK B cells were seeded onto 24 well cover
slips at 1 x 104 cell density, and treated with NGF for a
day. The cells were then fixed in 4% PF for 10 minutes,
The cells were then incubated with 1X Duolink blocking
stock for 1 hour, before overnight incubation at 4°C with
the primary antibodies. Both the anti-goat-plus and anti-
rabbit-minus PLA probes were added to the diluent in
1:10 ratio. Next, the cells were washed with 1X TBS-T
and the diluted PLA probes were incubated with the
samples in a humidity chamber for 2 hours at 37°C. The
coverslips were washed and hybridisation solution was
added and the samples were incubated for 15 minutes at
37°C. The coverslips were washed with 1X TBS-T and
Duolink Ligase was added to the ligation solution at 1:40
dilution, and incubated for 15 minutes at 37°C. The cov-
erslips were washed with 1X TBS-T and Duolink Poly-
merase was added to the diluted amplification solution
at 1:80 dilution, before addition to samples and incuba-
tion for 90 minutes at 37°C. The slides were then washed
with 1X TBS-T. The detection solution was added to
the samples and incubated for 60 minutes at 37°C. The
slides were then washed in 2xSSC for 2minutes, 1x SSC
for 2 minutes, 0.2x SSC for 2 minutes, 0.02x SSC for
2 minutes and 70% ethanol for 1 minutes before the
samples were left to dry. The coverslips were then
mounted on slides using Vectashield Mounting Medium
with DAPI (Vector Labs, USA) and examined using con-
focal microscopy (Fluoview1000, Olympus, Japan).
Brd-U(5-bromo-2’-deoxy-uridine) staining
The cells were transfected as mentioned above, before
they were reseeded at 50% confluency. The number of
proliferating cells was visualized and counted using the
BrdU Labeling and Detection Kit I by Roche. In brief,
the cell culture medium was aspirated and the cells were
incubated with BrdU labeling medium for 30 minutes at
37°C and 5% CO2. The cells were washed before they
were fixed in ethanol for half an hour at −20°C, washed
and then incubated with the Anti-BrdU working solution
for 30 minutes at 37°C. After washing, Anti-mouse-Ig-
fluorescein working solution was added to the cells and
incubated for 30 min at 37°C. After a final 3 washes, the
coverslips were mounted onto glass slides with Vecta-
shield Mounting Medium with DAPI (Vector Labs,
USA) and photos were taken using the confocal
microscope.
MTS assay
In order to study if the NGF treatment had decreased
the proliferation rate of the cells, cell numbers were
assayed using CellTiter 96® Aqueous Non-Radioactive
Cell Proliferation Assay (Promega), a colorimetric based
technique that exploits the ability of viable cells to
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were plated at a fixed number in 100 μl of cell medium
into a 96-well plate and allowed to equilibrate for
2 hours. Thereafter, 100 μl of PMS solution was added
to 2 ml of MTS solution, and 20 μl of the PMS/MTS
solution was added to each well. The plate was then
incubated for 2.5 hours in an incubator at 37°C and 5%
CO2. The absorbance for the plate was then read at
490nm in the GENios plate reader (Tecan, Switzerland).
Flow cytometry
The cells were serum starved so that they would be
synchronised. At the designated time point, the cells
were washed with 1xPBS, trypsinized and spun down at
1500 rpm, 4°C for 5 minutes. The cell pellet was then
resuspended in 70% ethanol and left on ice for a mini-
mum of 2 hours, or incubated at 4°C overnight so as
to fix the cells. Before flow cytometry analysis using
Beckman Coulter Epics Altra, USA), the ethanol was
removed, and the cells washed with 1xPBS once. 1ml of
the propidium iodide mixture (1xPBS, 0.1% triton X-
100, 0.2mg/ml RNase A, 20ug/ml PI) was then added to
the cells, and incubated at 37°C for 15 minutes.
Statistical analyses
All the experiments were repeated at least in triplicate
for statistical purpose, and where appropriate, the data
were presented as mean and standard deviation (SD).
When comparing only two groups, the quantitative data
was statistically evaluated using the Student’s t-test.
When comparison was made between groups, one-way
ANOVA was used. The level of significance was set
at p<0.05.
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